Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OK › Tulsa › NPI 1629057229
Hospital

Ahs Hillcrest Medical Center, LLC

Ahs Hillcrest Medical Center, LLC was paid $14.37M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99285, emergency room visit (most serious) — 38% of everything it billed.

33Billing provider infoAHS HILLCREST MEDICAL CENTER, LLC
TULSA, OK 74104
33aNPI1629057229assigned 01/11/2006
28Total paid$14.37M
24GClaims167,561
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Oklahoma

Rank by total paid#10 of 75
Median peer was paid$3.66M
This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201820,311$1.69M
201917,913$1.39M
202017,917$1.43M
202120,179$1.53M
202232,835$2.89M
202340,387$3.79M
2024incomplete18,019$1.65M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 38% 16,784 16,421 $5.43M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 28% 17,134 16,841 $4.06M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 14,701 14,210 $2.27M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.7% 6,430 6,308 $827K
D9999 Unspecified adjunctive procedure, by report 3.5% 495 494 $501K
80053 Comprehensive metabolic panel 1.2% 18,054 16,786 $167K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,312 19,368 $143K
36415 Collection of venous blood by venipuncture <1% 23,773 21,303 $137K
96375 Therapeutic injection; each additional sequential IV push <1% 2,674 2,534 $108K
71045 Radiologic examination, chest; single view <1% 6,818 6,632 $86K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 835 835 $72K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,848 9,369 $61K
62 more codes
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,943 $57K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 310 $52K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 186 $42K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 296 $41K
84484 <1% 2,950 $37K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 206 $31K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 76 $27K
95811 <1% 82 $25K
70450 Computed tomography, head or brain; without contrast material <1% 425 $22K
81002 <1% 6,139 $20K
96361 Intravenous infusion, hydration; each additional hour <1% 435 $16K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 152 $15K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 520 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 208 $10K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 39 $10K
83880 <1% 307 $10K
81001 <1% 3,180 $10K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 139 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,203 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 149 $8K
81025 <1% 1,088 $8K
83690 <1% 1,232 $7K
43235 <1% 12 $6K
76801 <1% 79 $5K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 95 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 52 $5K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 36 $4K
83735 <1% 376 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 283 $2K
86850 <1% 265 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 52 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 52 $2K
84702 <1% 118 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 22 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 17 $867.81
83605 <1% 65 $812.91
86900 <1% 292 $795.69
86901 <1% 278 $752.42
71046 Radiologic examination, chest; 2 views <1% 35 $549.00
87210 <1% 93 $434.49
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 28 $411.60
82962 <1% 136 $396.96
82803 <1% 12 $324.66
87040 <1% 17 $293.76
97597 <1% 33 $291.70
81003 <1% 136 $254.14
82553 <1% 14 $211.14
87807 <1% 16 $186.40
J3010 Injection, fentanyl citrate, 0.1 mg <1% 151 $140.70
82550 <1% 14 $118.98
J7030 Infusion, normal saline solution , 1000 cc <1% 1,343 $89.10
87081 <1% 13 $72.70
84550 <1% 12 $55.08
82247 <1% 12 $53.64
J7050 Infusion, normal saline solution, 250 cc <1% 526 $53.08
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 687 $1.34
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 287 $0.27
J7120 Ringers lactate infusion, up to 1000 cc 0% 1,056 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 596 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 94 $0.00
96376 0% 21 $0.00
36416 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOBBS, STEVE (CEO)
Same official

Other billing entities under DOBBS, STEVE

Full network →
ProviderLocationPaid
Secure Transportation Company, INCCerritos, CA$53.78M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.